dr. tolaney on the advantages of ctdna versus tissue biopsy in breast cancer
Published 4 years ago • 124 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
1:58
dr. tolaney on presence of pik3ca and esr1 mutations in monarch 2 trial in breast cancer
-
1:16
dr. husain on liquid biopsy versus tissue biopsy in nsclc
-
2:06
dr. tolaney on deescalating therapy in stage i her2 breast cancer
-
1:10
dr. tolaney discusses unmet needs in er breast cancer
-
1:10
dr. ocean discusses the use of ctdna in pancreatic cancer
-
0:42
what future does ctdna have as a biomarker in breast cancer?
-
7:26
ctdna testing in hormone receptor-positive mbc
-
1:26
potential role of ctdna for early-stage breast cancer
-
2:13
dr. bach on examining ctdna in crc
-
12:59
debate: liquid biopsy will replace tissue biopsy? - yes
-
2:26
dr. goetz on the use of ctdna in the monarch-3 trial in hr /her2- breast cancer
-
1:17
the emerging role of ctdna analysis and liquid biopsies in oncology
-
55:46
liquid biopsy in breast cancer: a journey through innovation, discoveries and clinical applications
-
0:55
dr. polsky on the unmet need of clinical utility in liquid biopsy
-
2:28
circulating tumor dna (ctdna) in breast cancer: 2023 coeds ft lauderdale conference
-
1:07
clinical relevance of lipid biopsy and circulating tumor cells for precision medicine
-
1:33
dr. sparano on improving liquid biopsies in breast cancer
-
14:55
2020 ttf am session weiss - role of liquid biopsies vs tissue biopsies
-
1:39
dr. alan miller on benefits of liquid biopsy